Role and regulation of Yap in KrasG12D-induced lung cancer
Open Access
- 2 December 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (67) , 110877-110889
Abstract
Role and Regulation of Yap in Kras G12D -induced lung cancer Role and Regulation of Yap in KrasG12D-induced lung cancerKeywords
This publication has 51 references indexed in Scilit:
- Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing PathwaysTrends in Cell Biology, 2016
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerCell, 2015
- Hippo‐YAP signaling pathway: A new paradigm for cancer therapyInternational Journal of Cancer, 2014
- KRAS Mutations in Lung CancerClinical Lung Cancer, 2013
- Regulation of Hippo Signaling by EGFR-MAPK Signaling through Ajuba Family ProteinsDevelopmental Cell, 2013
- Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1Proceedings of the National Academy of Sciences, 2013
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in MammalsDevelopmental Cell, 2010
- The Differential Effects of Mutant p53 Alleles on Advanced Murine Lung CancerCancer Research, 2005
- Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasGenes & Development, 2001